Patanjali Ayurveda Treatment Left Kidney Patient With Worsening Disease, Doctor Warns
A nephrologist warned that Patanjali's Haridwar center gave hydrotherapy to a CKD patient with a creatinine of 12, with the sessions covered by health insurance.
The creatinine was 12. A nephrologist who publicly flagged the case of a chronic kidney disease patient treated at Patanjali Ayurveda's Haridwar facility says that number was not enough to stop the center from administering hydrotherapy and mud therapy.
The patient, already managing CKD, had traveled to Patanjali's Haridwar center in 2025. The initial visit produced what appeared to be a marginal improvement in symptoms, enough to give the patient confidence in the treatment. Then, in February 2026, his condition suddenly collapsed. His creatinine, the blood marker clinicians use to track how effectively the kidneys are filtering waste, shot up to 12, a level that signals advanced kidney failure and demands immediate specialist escalation.
The treatments the center had administered included hydrotherapy and mud therapy on the patient while his creatinine stood at 12. For patients with significantly compromised kidney function, the cardiovascular strain and fluid shifts associated with water-based physical therapy carry documented risks that any responsible protocol must account for. Patanjali Wellness centers publicly list hydrotherapy, mud therapy, sun therapy, ozone steam sauna, whirlpool baths, and circular jet massage among their naturopathy offerings. Whether the Haridwar facility maintained any written contraindication protocol specifying lab thresholds that would disqualify CKD patients from specific treatments has not been publicly established.
After the patient's condition deteriorated, he called the center seeking guidance. According to the nephrologist's account, the response from a practitioner there amounted to an open invitation to return, with no referral back to the treating specialist and no emergency escalation of any kind.
What struck the nephrologist as equally alarming was the insurance dimension: the patient's health insurance had covered the treatment at Patanjali. When a policy meant to protect a patient's health underwrites alternative therapies that the patient's specialist never approved, it creates a risk loop with no built-in circuit breaker. The nephrologist flagged this as a systemic enabler, not a one-off administrative error.
Patanjali, the brand that Baba Ramdev built on the commercial power of yoga and Ayurveda and one of the most visible names in India's integrative health market, has not issued a public statement on this case. India's regulators overseeing Ayurvedic practice standards have not publicly addressed the insurance coverage question the nephrologist raised.
For anyone managing a serious chronic condition who is considering integrative treatment, the case makes the minimum due-diligence questions explicit: Will the center directly coordinate with your nephrologist and share all lab documentation before initiating any therapy? Does the facility maintain a written contraindication protocol that specifies which test thresholds, creatinine, eGFR, or otherwise, disqualify a patient from individual treatments? Has your current kidney function been reviewed and cleared by both the center's practitioners and your specialist before any session begins? And does your insurer require specialist coordination before covering alternative therapies for patients with stage 4 or 5 kidney disease?
The line between yoga-adjacent wellness culture and evidence-based nephrology care was never designed to blur this quietly.
Know something we missed? Have a correction or additional information?
Submit a Tip
